HUPO 2013 Meeting of the Minds

This unique event provides the opportunity for you to meet with HUPO keynote speakers and dignitaries during Agilent's cocktail reception. This gathering's format will consist of 15-20 minute intervals for personal discussions with one or two dignitaries at a time, and then rotate to another table for additional discussions with other thought leaders in the proteomics field.

Don't miss this excellent networking opportunity!

Register below and pick up your ticket for entry on Sunday morning at Agilent Booth #58
Space is limited – ticket required for entry.

[ Themes ]

QC or Bust: Performance Assessment for Quantitative Plasma Proteomics by MRM
Christoph Borchers, Ph.D., University of Victoria – Genome BC Proteomics Centre, Victoria, BC, Canada

Defining the Next Experiment:
Pathway - directed Analysis from Protein Discovery Data
Christine Miller, Senior Application Scientist, Agilent Technologies

Learn how pathway knowledge can be used to create targeted proteomics experiments to verify and validate candidate disease biomarkers in complex matrices. Examples are shown in the seminar. For some targeted assays, absolute quantitation is key to finding the true biological differences. In order to enable the acquisition of more precise and accurate quantitative data, two reference kits were developed by MRM Proteomics using SIS peptide approach for undepleted and non-enriched human plasma.